Overexpression of CIP2A is associated with poor prognosis in multiple myeloma
Sign Up to like & getrecommendations! Published in 2017 at "Signal Transduction and Targeted Therapy"
DOI: 10.1038/sigtrans.2017.13
Abstract: Cancerous inhibitor of protein phosphatase 2A (CIP2A), an endogenous protein phosphatase 2A (PP2A) inhibitor, has been identified as an oncoprotein in promoting cancer initiation and progression of several types of cancer. However, the expression and… read more here.
Keywords: overexpression cip2a; prognosis; cip2a; multiple myeloma ... See more keywords